Guidance
← Отчётные звонки
01
02
03
04 05 06
Тон
A1 A2 A3
BRO
FY2025 Q4
Улучшается
Отчётный звонок Brown & Brown, Inc.
Вывод Buzzberg
Cautiously optimistic about 2026 organic growth
Brown & Brown reported a strong Q4 with significant total revenue growth driven by M&A, but organic growth was negative due to a tough comparison from prior-year flood revenue. Management discusses the impact of falling E&S property rates, rising employee benefits costs, and the competitive threat from a startup broker poaching talent. Q4 total revenues grew 35.7% to $1.6B, but organic revenue decreased 2.8% due to prior-year flood claims processing revenue.
Вывод Buzzberg Cautiously optimistic about 2026 organic growth Brown & Brown reported a strong Q4 with significant total revenue growth driven by M&A, but organic growth was negative due to a tough comparison from prior-year flood revenue. Management discusses the impact of falling E&S property rates, rising employee benefits costs, and the competitive threat from a startup broker poaching talent. Q4 total revenues grew 35.7% to $1.6B, but organic revenue decreased 2.8% due to prior-year flood claims processing revenue. Читать полный анализСвернуть анализ
Brown & Brown reported a strong Q4 with significant total revenue growth driven by M&A, but organic growth was negative due to a tough comparison from prior-year flood revenue. Management discusses the impact of falling E&S property rates, rising employee benefits costs, and the competitive threat from a startup broker poaching talent. Q4 total revenues grew 35.7% to $1.6B, but organic revenue decreased 2.8% due to prior-year flood claims processing revenue.
- The company completed a record year for M&A, adding ~$1.8B of annual revenue, led by the acquisition of AssuredPartners.
- Management notes increased competition from a startup broker (implied to be Howden) that poached 275 employees and took $23M in known annual revenues.
- Property catastrophe reinsurance rates are declining 15-30%, and some binding authority business is moving back to the admitted market.
Выручка$1.669BФакт
EPS$0.93Факт
Валовая маржа83.82%Факт
Операционная маржа25.7%Факт
6 подтверждённых тезисов
Что важно сейчас
Самые значимые изменения по итогам звонка.
Margins
Raising long-term margin target range to 32-37%
Competition
Startup broker poaches 275, taking $23M revenue
Показать ещё 3 тезиса
Pricing
Expect continued moderation in casualty rate increases
Pricing
Expect cap property rates to decline modestly
M&A
Integration of AssuredPartners on track, synergies expected
Отчётный период
Фактические результаты
| Показатель | Факт | Изменение |
|---|---|---|
| Выручка | $1.669B | Факт |
| EPS | $0.93 | Факт |
| Валовая маржа | 83.82% | Факт |
| Операционная маржа | 25.7% | Факт |
| Свободный денежный поток | $0.424B | Факт |
| Капзатраты | $0.02B | Факт |
Прогнозные данные
Прогноз компании
| Показатель | Период | Диапазон | Середина | Статус |
|---|---|---|---|---|
| Операционная маржа | FY2026 | 32%–37% | 34.5% | Повышен |
AI, капзатраты и спрос
Оценка менеджмента
Measured
Management strikes a balanced, confident tone, acknowledging headwinds like the poaching of teammates and market softening while emphasizing strong cash flow and disciplined execution.
все упомянутые компании ниже: 3
Компаниис момента звонка
Цепочка поставок
Цепочка поставок
Powell Brown
Employee benefits pricing for medical and pharmacy costs is rising sharply (medical +7-9%, pharmacy +10%), indicating persistent healthcare cost inflation. — Sustained high medical/pharmacy costs suggests robust pricing power for major health insurers and pharmacy benefit managers (PBMs), potentially supporting their revenue growth.
Доказательства
“Pricing for employee benefits increased slightly as compared to prior quarters, with medical costs up 7% to 9% and pharmacy costs up over 10%.”
Цепочка поставок
Andy
Business is moving from the E&S market to the admitted market due to competitive pricing, but the long-term trend still favors more insured assets moving into the E&S space. — Despite cyclical shifts, secular demand for flexible E&S capacity remains strong, benefiting carriers like Chubb that underwrite surplus lines.
Доказательства
“we continue to believe that there's going to be more insured assets, though, moving into the ENS space versus moving back into the admitted.”
Внешние сигналы
Альфа цепочки поставок · 3с момента звонка
The decrease in excess & surplus (E&S) property rates is driving some binding authority business to move back into the admitted market, a cyclical shift that could pressure specialty distribution organic growth.
Доказательства
“we saw some binding authority business move back into the admitted market.”
Employee benefits pricing for medical and pharmacy costs is rising sharply (medical +7-9%, pharmacy +10%), indicating persistent healthcare cost inflation.
Business is moving from the E&S market to the admitted market due to competitive pricing, but the long-term trend still favors more insured assets moving into the E&S space.
Методология и полнота
Анализ основан только на заявлениях менеджмента. Показаны все подтверждённые упоминания компаний: 3. Фактические результаты и прогнозы разделены. Публичные доказательства ограничены восемью короткими атрибутированными цитатами. AI-анализ может быть неполным или ошибочным — проверяйте важные утверждения по первоисточнику.